Recruitment

Recruitment Status
Terminated
Estimated Enrollment
12

Inclusion Criterias

Patients must be receiving stable or increasing doses of morphine for 1-2 weeks prior to registration for protocol therapy.
Patients with histologically confirmed diagnosis of cancer NOTE: Patients with active cancer or post treatment are allowed on the study.
Patients must be receiving stable or increasing doses of morphine for 1-2 weeks prior to registration for protocol therapy.
Patients with histologically confirmed diagnosis of cancer NOTE: Patients with active cancer or post treatment are allowed on the study.

Summary

Conditions
Cancer
Type
Interventional
Phase
Phase 1
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Supportive Care

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criterias

Patients must be receiving stable or increasing doses of morphine for 1-2 weeks prior to registration for protocol therapy.
Patients with histologically confirmed diagnosis of cancer NOTE: Patients with active cancer or post treatment are allowed on the study.
Patients must be receiving stable or increasing doses of morphine for 1-2 weeks prior to registration for protocol therapy.
Patients with histologically confirmed diagnosis of cancer NOTE: Patients with active cancer or post treatment are allowed on the study.

Locations

Indianapolis, Indiana, 46202
Indianapolis, Indiana, 46202
Indianapolis, Indiana, 46202
Indianapolis, Indiana, 46202

Tracking Information

NCT #
NCT02078089
Collaborators
Not Provided
Investigators
  • Principal Investigator: Costantine Albany, M.D. Indiana University
  • Costantine Albany, M.D. Indiana University